How and when is POLIVY administered?
POLIVY is given in combination with a cancer treatment regimen that includes bendamustine and rituximab product.
POLIVY is administered as an intravenous infusion (directly into the vein) at a clinic or infusion center.
Your doctor may have you take medicine before your infusion. Over the first 2 days of each treatment cycle, you will be given POLIVY, bendamustine, and rituximab product. Typically, you will have 3 weeks before the next treatment cycle is given. It is recommended to receive the POLIVY combination for a total of 6 cycles; however, your doctor will decide how many cycles you need. Talk to your doctor about how you will receive POLIVY.
Example of a POLIVY combination treatment schedule
- Day 1: POLIVY is administered in combination with bendamustine and rituximab product
- Day 2: Bendamustine alone is administered
Some people may experience side effects during and after the infusion process. Please see Preparing for your infusion for more information about these reactions. If you have questions about dosing or the infusion process, talk to your doctor.